Keryx Biopharmaceuticals (KERX)

Add to Watchlists Create an Alert
7.98 +0.10  +1.27%   NASDAQ May 23, 1:01PM BATS Real time Currency in USD

Keryx Biopharmaceuticals Net Income Quarterly:

-6.628M for Dec. 31, 2012
View Full Chart

Keryx Biopharmaceuticals Net Income Quarterly Chart

    Keryx Biopharmaceuticals Historical Net Income Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -6.628M
    Sept. 30, 2012 -5.475M
    June 30, 2012 -1.504M
    March 31, 2012 -9.114M
    Dec. 31, 2011 -8.375M
    Sept. 30, 2011 -10.25M
    June 30, 2011 -3.096M
    March 31, 2011 -6.405M
    Dec. 31, 2010 -5.314M
    Sept. 30, 2010 -5.848M
    June 30, 2010 -5.154M
    March 31, 2010 -4.015M
    Dec. 31, 2009 -4.658M
    Sept. 30, 2009 0.56M
    June 30, 2009 14.13M
    March 31, 2009 0.451M
    Dec. 31, 2008 -3.807M
    Sept. 30, 2008 -6.841M
    June 30, 2008 -7.697M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Net Income

    Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

    Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
    Learn More

    Get data for

    KERX Net Income Quarterly Benchmarks

    Companies
    Supernus Pharmaceuticals -13.51M
    Aegerion Pharmaceuticals -18.14M
    Sucampo Pharmaceuticals 13.53M

    KERX Net Income Quarterly Rankings

    Overall 38th percentile
    4891 of 8006
    Sector 25th percentile
    508 of 686 in Healthcare
    Industry 33rd percentile
    45 of 68 in Drug Manufacturers - Specialty & Generic

    KERX Net Income Quarterly Range, Past 5 Years

    Minimum -10.25M Sep 2011
    Maximum 14.13M Jun 2009
    Average -4.160M